Ruitao Lin

Dr. Ruitao Lin is an Assistant Professor in the Department of Biostatistics at The University of Texas MD Anderson Cancer Center and an Adjunct Assistant Professor at Rice University. He holds a PhD in Biostatistics from The University of Hong Kong (2012–2016) and completed postdoctoral training at the University of Washington and MD Anderson. His research focuses on Bayesian adaptive designs, robust statistical methods, and clinical trial methodologies, particularly in oncology and precision medicine. He leads the development of novel Bayesian approaches for dose-finding in phase I/II trials, meta-analytic trial designs, and high-dimensional data analysis. Dr. Lin is an Associate Editor for Contemporary Clinical Trials, Biometrical Journal, and Pharmaceutical Statistics, and has contributed to software tools like the BOIN design suite and TITE-BOIN12.

His work bridges statistical innovation with practical clinical challenges, including late-onset toxicities in immunotherapy and heterogeneous treatment effects. He has secured NIH funding (e.g., R01CA261978) and collaborated with academic and industry partners to advance trial design and analysis. His software platforms, including R packages and Shiny apps, enable clinicians to implement cutting-edge statistical methods in real-world settings.

• Education: PhD, Biostatistics, The University of Hong Kong (2016); Postdocs at University of Washington (2016–2017) and MD Anderson (2017–2019).
• Grants: NIH/NCI R01CA261978 (2021–2025), focusing on Bayesian methods for precision oncology trials.
• Teaching: Teaches clinical trial design courses at Rice University and UTHealth.
• Labs/Software: Developed the BOIN design suite, TITE-BOIN12, and other tools for dose-finding and phase I/II trials.